Offstream
news

---

Changes

1. The Maldives Food and Drug Authority approves the emergency use of the Pfizer–BioNTech and Sinopharm BBIBP-CorV vaccines.
   2021-03-16 01:06:08 (First version)
2. The Maldives Food and Drug Authority approves the emergency use of the Pfizer–BioNTech and the Sinopharm BBIBP-CorV vaccines.
   (Current version)

---

Related

Cambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third "booster" dose to people who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (CoronaVac) in order to strengthen immunity against the SARS-CoV-2 Delta variant.
2021-08-12

The Ministry of Health approves the emergency use of the Sinopharm BBIBP-CorV vaccine for children between the ages of 3 and 17 years old in the UAE.
2021-08-2

Sri Lanka receives 600,000 doses of the Sinopharm BBIBP-CorV vaccine from China. Vaccination of Chinese nationals could commence first as the Medicines Regulatory Authority says that the vaccination of Sri Lankans will begin after a study by a committee of experts.
2021-03-31

Pakistan Prime Minister Imran Khan receives his first dose of the Sinopharm BBIBP-CorV vaccine.
2021-03-18

The Drug Regulatory Authority of Pakistan grants emergency use authorisation of the Sinopharm BBIBP-CorV vaccine for people over 60 years of age.
2021-03-5

Venezuela approves the emergency use of Sinopharm BBIBP-CorV vaccine.
2021-03-1

Iran receives their first shipment of 250,000 doses of the Sinopharm BBIBP-CorV vaccine.
2021-02-28

Argentina receives the first shipment of 904,000 doses of Sinopharm's BBIBP-CorV vaccine.
2021-02-25

Peru launches a vaccination program against COVID-19 two days after it received 300,000 doses of Sinopharm's BBIBP-CorV vaccine. President Francisco Sagasti becomes the first person to get vaccinated.
2021-02-9

Egypt approves the use of Sinopharm's BBIBP-CorV vaccine, with the vaccination campaign expected to start later this month. Egypt plans to buy 40 million doses of this vaccine.
2021-01-3